Ignite Creation Date:
2025-12-24 @ 5:06 PM
Ignite Modification Date:
2026-01-03 @ 10:23 PM
Study NCT ID:
NCT06470750
Status:
RECRUITING
Last Update Posted:
2025-07-22
First Post:
2024-06-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) With Prostate Cancer (CaP)
Sponsor:
Mayo Clinic
Organization:
Study Overview
Official Title:
Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) With Advanced Prostate Cancer (CaP)
Status:
RECRUITING
Status Verified Date:
2025-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluates the possibility of patient-centered home care as a new model of cancer care to reduce disparities and improve health related quality of life and patient-reported outcomes in Black patients with prostate cancer.
Detailed Description:
PRIMARY OBJECTIVES:
I. To evaluate a highly innovative project evaluating the feasibility of patient-centered home care PCHC as a new model of cancer care to reduce disparities and improve health related QoL (HRQoL) and patient reported-outcomes (PROs) in Black patients with advanced prostate cancer (CaP). (Phase I) II. Establish patient-centeredness by exploring patients' choice relative to the place of CaP treatment for certain aspects of therapy as well as end-of-life care.
III. Establish the acceptance and impact of PCHC on PROs and HRQoL in BM with advanced CaP.
OUTLINE: This is an observational study. Participants are assigned to 1 of 2 groups.
GROUP 1: Participants take part in a focus group or complete questionnaires and may take part in an interview on study.
GROUP 2: Participants complete questionnaires throughout the study.
I. To evaluate a highly innovative project evaluating the feasibility of patient-centered home care PCHC as a new model of cancer care to reduce disparities and improve health related QoL (HRQoL) and patient reported-outcomes (PROs) in Black patients with advanced prostate cancer (CaP). (Phase I) II. Establish patient-centeredness by exploring patients' choice relative to the place of CaP treatment for certain aspects of therapy as well as end-of-life care.
III. Establish the acceptance and impact of PCHC on PROs and HRQoL in BM with advanced CaP.
OUTLINE: This is an observational study. Participants are assigned to 1 of 2 groups.
GROUP 1: Participants take part in a focus group or complete questionnaires and may take part in an interview on study.
GROUP 2: Participants complete questionnaires throughout the study.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| W81XWH2210969 | OTHER_GRANT | Department of Defense | View | |
| W81XWH2210968 | OTHER_GRANT | Department of Defense | View | |
| NCI-2024-04792 | REGISTRY | CTRP (Clinical Trial Reporting Program) | View | |
| 22-004375 | OTHER | Mayo Clinic Institutional Review Board | View | |
| CaP PCHC | OTHER | Mayo Clinic in Florida | View |